Live News REGULATION FLASH L impact Nov 05, 2026, 12:01 AM UTC HUTCHMED Says FDA Granted Sovleplenib Orphan Drug Designation The designation is for sovleplenib in autoimmune hemolytic anemia. SquawkNews Desk